Medpace Holdings Inc

6 нояб. 2026 г., 21:02 UTC

Charles River Laboratories is sharply higher following an analyst upgrade from Mizuho, moving in sympathy with Medpace Holdings, which is also trading higher.

5 нояб. 2026 г., 21:04 UTC

Medpace Holdings, Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, raising governance concerns.

4 нояб. 2026 г., 21:07 UTC

Medpace Holdings, Inc. shares are declining amid a broader market downturn, as Charles River Laboratories reported a revenue decline and lowered fiscal guidance.

3 нояб. 2026 г., 21:02 UTC

Medpace Holdings, Inc. is trading higher, reflecting strong performance as it remains above its 20-day moving average, contrasting with the previous three sessions.

30 окт. 2026 г., 20:03 UTC

Medpace Holdings, Inc. shares are declining, paralleling a drop in Charles River Laboratories, amid a sharp overall market decline during Friday's trading session.

29 окт. 2026 г., 19:26 UTC

Medpace Holdings, Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential claims of corporate misconduct involving certain officers or directors.

28 окт. 2026 г., 20:02 UTC

Medpace Holdings, Inc. is trading higher, reflecting positive momentum since Tuesday's close, alongside a notable increase in shares of Charles River Laboratories.

27 окт. 2026 г., 19:36 UTC

Medpace Holdings, Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing claims involving the company and its officers or directors.

23 окт. 2026 г., 20:08 UTC

Medpace Holdings Inc received multiple price target increases today, with Mizuho raising its target to $730 and Baird to $699, among others.

22 окт. 2026 г., 20:03 UTC

Bronstein, Gewirtz & Grossman, LLC is investigating Medpace Holdings, Inc. for potential corporate misconduct involving the company and its executives.

21 окт. 2026 г., 22:02 UTC

Medpace Holdings reported Q3 EPS of $4.84, exceeding estimates, and raised FY 2026 EPS guidance, but shares fell in after-hours trading amid revenue concerns.

20 окт. 2026 г., 20:08 UTC

Citrini Research's bullish outlook on Charles River Laboratories has driven shares higher, while Medpace Holdings remains stable near the upper end of its trading range.

16 окт. 2026 г., 20:07 UTC

Medpace Holdings Inc shares are declining, finishing significantly lower since Thursday's close, despite a slight recovery earlier in the session.

15 окт. 2026 г., 20:07 UTC

Medpace Holdings Inc shares advanced during Thursday's session, supported by a maintained Buy rating on Thermo Fisher Scientific Inc and strong user commentary on performance.

14 окт. 2026 г., 20:07 UTC

Medpace Holdings Inc shares are advancing, following an early surge that marked its highest cumulative return, despite some retracement during Wednesday's trading session.

12 окт. 2026 г., 19:56 UTC

Medpace Holdings Inc is trading higher, having gained traction since Friday and currently positioned above its 20-day moving average.

9 окт. 2026 г., 20:06 UTC

Medpace Holdings Inc is advancing, benefiting from broader market gains since Thursday, despite pulling back slightly from an earlier session peak.

8 окт. 2026 г., 21:40 UTC

Medpace Holdings Inc is trading lower in after-market hours, continuing a decline since Thursday's close and indicating ongoing weakness below its 20-day moving average.

6 окт. 2026 г., 20:00 UTC

Medpace Holdings Inc shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

5 окт. 2026 г., 20:01 UTC

Charles River Laboratories is sharply higher after a positive earnings report, while Medpace Holdings is also advancing, despite earlier pulling back from a session high.

1 окт. 2026 г., 20:02 UTC

Medpace Holdings Inc shares fell amid a broader market decline, reversing the recent trend of higher daily closes since Wednesday's close.

30 сент. 2026 г., 19:35 UTC

UBS upgraded Medpace Holdings Inc to Neutral with a price target of $673, as shares trade higher amid strong historical performance despite recent insider selling.

25 сент. 2026 г., 20:07 UTC

Medpace Holdings Inc shares fell, reflecting a decline from Thursday's close, amid sympathy with Thermo Fisher Scientific Inc, which is also down.

24 сент. 2026 г., 20:07 UTC

Medpace shares are modestly higher as President and CEO August J. Troendle sold 70.9k shares for about $44.43 million, following strong revenue growth.

23 сент. 2026 г., 20:01 UTC

Medpace Holdings Inc shares fell sharply on Wednesday, aligning with a decline in Charles River Laboratories, despite remaining above its 20-day moving average.

22 сент. 2026 г., 23:01 UTC

Medpace Holdings Inc is rising in after-market trading, continuing a trend above its 20-day moving average and closing higher for three consecutive sessions.

15 сент. 2026 г., 20:01 UTC

Medpace Holdings Inc. is trading higher today despite negative broader market sentiment following a significant drop in the NY Empire State Manufacturing Index.

11 сент. 2026 г., 20:08 UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

3 сент. 2026 г., 20:07 UTC

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2 сент. 2026 г., 20:08 UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.